The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage
Yi-Che Lee,Chih-Ting Huang,Fong-Yu Cheng,Shih-Yuan Hung,Tsun-Mei Lin,Yen-Chang Tsai,Chih-I Chen,Hao-Kuang Wang,Chi-Wei Lin,Hung-Hsiang Liou,Min-Yu Chang,Hsi-Hao Wang,Yuan-Yow Chiou
DOI: https://doi.org/10.2147/IJN.S215717
IF: 7.033
2019-12-05
International Journal of Nanomedicine
Abstract:Yi-Che Lee, 1–3 Chih-Ting Huang, 4 Fong-Yu Cheng, 5 Shih-Yuan Hung, 3, 6 Tsun-Mei Lin, 7 Yen-Chang Tsai, 4 Chih-I Chen, 8 Hao-Kuang Wang, 9 Chi-Wei Lin, 10 Hung-Hsiang Liou, 11 Min-Yu Chang, 3 Hsi-Hao Wang, 3 Yuan-Yow Chiou 4, 12 1 Division of Nephrology, Department of Internal Medicine, E-DA Dachang Hospital/ I-Shou University, Kaohsiung, Taiwan; 2 School of Medicine, College of Medicine; 3 Division of Nephrology, Department of Internal Medicine, E-DA Hospital/ I-Shou University, Kaohsiung, Taiwan; 4 Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 5 Department of Chemistry, Chinese Culture University, Taipei, Taiwan; 6 School of Medicine for International Students; 7 Department of Laboratory Medicine; 8 Division of Colorectal Surgery, Department of Surgery; 9 Department of Neurosurgery; 10 Department of Medical Education, E-DA Hospital/ I-Shou University, Kaohsiung, Taiwan; 11 Division of Nephrology, Department of Medicine, Hsin-Jen Hospital, New Taipei City, Taiwan; 12 Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan Correspondence: Yi-Che Lee Division of Nephrology, Department of Internal Medicine, E-DA Hospital/I-Shou University, No.1, Yida Road, Jiaosu Village, Yanchao District, Kaohsiung City 82445, Taiwan, ROC Tel +886-7-6150011 ext. 5121 Email pipijer@gmail.com Yuan-Yow Chiou Institute of Clinical Medicine, Department of Pediatrics, National Cheng Kung University Hospital, Medical College, No. 138, Sheng-Li Road, Tainan City 701, Taiwan, ROC Tel +886-6-2353535 ext. 4184 Fax +886-6-2753083 Email yuanyow@mail.ncku.edu.tw Purpose: Vitamin D is a novel potential therapeutic agent for peritoneal dialysis (PD)-related peritoneal fibrosis, but it can induce hypercalcemia and vascular calcification, which limits its applicability. In this study, we create nanotechnology-based drug delivery systems to investigate its therapeutics and side effects. Materials and methods: 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N- [amino-(polyethylene glycol)2000] (DSPE-PEG) and L-α-phosphatidylcholine (PC), which packages with 1α,25(OH) 2 D 3 , were used to construct vitamin D nanoliposomes. To confirm the function and safety of vitamin D nanoliposomes, peritoneal mesothelial cells were treated with TGF-β1 and the reverse was attempted using vitamin D nanoliposomes. Antibodies (Ab) against the peritoneum-glycoprotein M6A (GPM6A) Ab were conjugated with vitamin D nanoliposomes. These particles were implanted into mice by intraperitoneal injection and the animals were monitored for the distribution and side effects induced by vitamin D. Results: Vitamin D nanoliposomes were taken up by the mesothelial cells over time without cell toxicity and it also provided the same therapeutic effect in vitro. In vivo study, fluorescent imaging showed vitamin D nanoliposomes allow specific peritoneum target effect and also ameliorate vitamin D side effect. Conclusion: Nanoliposomes vitamin D delivery systems for the prevention of PD-related peritoneal damage may be a potential clinical strategy in the future. Keywords: peritoneal dialysis, nanoliposome, vitamin D, fibrosis
pharmacology & pharmacy,nanoscience & nanotechnology